The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
Share
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
HHS Looks to Centralize IT Buying, Speed Access to Emerging Tech
HHS is centralizing IT procurement while pursuing faster acquisition tools for AI and other emerging technologies.
9m watch -
VA Employees Save 6 Hours a Week With AI Tools
VA AI chief Kimberly McManus said AI tools are helping improve veteran care, reduce opioid overdose mortality and save time for employees.
4m watch -
FEHRM CTO: TEFCA Could Take Federal Health Data Exchange to ‘Next Evolution’
FEHRM CTO Lance Scott discusses efforts to modernize and improve interoperability of electronic health records across the federal government.
7m watch -
Inside ASPR’s Efforts to Bolster Healthcare Sector Cyber Resilience
HHS ASPR’s Bob Bastani details how governance, standards and migration planning can help against emerging threats to medical data and devices.
12m watch
